Why it Matters

The Senate Judiciary Committee is set to hold a hearing o that arrives amid a drumbeat of espionage arrests, damning investigative reports, and billions of dollars in lobbying activity from industries that say they're hemorrhaging trade secrets to Beijing. The China theft innovation hearing, chaired by Sen. Chuck Grassley (R-IA), with Ranking Member Sen. Dick Durbin (D-IL), represents the committee's most direct confrontation yet with a problem that cuts across defense, technology, pharmaceuticals, and trade.

What's Driving the Senate Judiciary Committee Hearing on China

In the weeks leading up to the hearing, several high-profile reports have underscored the scope of China intellectual property theft targeting American companies and defense systems:

  • March 10, 2026: Three individuals were arrested on espionage charges for allegedly selling sensitive weapons positioning system information to China since 2022, according to AFP reporting.

  • February 13, 2026: A Bloomberg investigation detailed how Chinese spies systematically targeted the U.S. aviation industry — including a senior Boeing engineer — to steal trade secrets related to jet engines and composite materials. The story drew on FBI data and documented years-long espionage campaigns by China's Ministry of State Security.

  • February 19, 2026: Foreign Policy published a deep analysis of how decades of Chinese espionage have eroded American technological and military advantages. The piece criticized the Trump administration for reportedly moving "largely in the opposite direction" — allowing the sale of advanced semiconductor chips to China, removing Commerce Department officials focused on Chinese tech threats, and dismantling U.S. cyber defenses against Chinese hacking.

  • February 25, 2026: China's own top prosecutorial agency announced an escalation in domestic intellectual property theft prosecutions, with officials acknowledging a growth in cases involving theft of trade secrets. Analysts at CSIS described China's state-supported IP theft as "part of a larger industrial strategy" involving subsidies, trade barriers, and "licit and illicit acquisition of foreign technology."

  • An opinion piece in The Hill raised alarms about U.S. administrative law judges allegedly undermining IP protections, calling it "a direct assault on American innovation and the Trump administration's efforts to crack down on Chinese intellectual property theft."

    • Taken together, these reports paint a picture of a US innovation theft problem that is accelerating even as policy responses remain fragmented.

    The Lobbying Machine Behind the Hearing on China Stealing US Technology

    Industries are spending heavily to push for stronger IP protections and export controls. Recent reporting suggests the administration may be weakening some of the very enforcement mechanisms designed to counter China's technology acquisition efforts. And new espionage arrests continue to demonstrate that the threat is active, not theoretical.

    Industry Is spending big on lobbying and naming China directly. That's because the outcome of this policy debate will have direct financial consequences.

    Lobbying disclosure records from the past four quarters reveal sustained, high-dollar pressure campaigns from industries directly affected by Beijing's technology acquisition strategies.

    The International Intellectual Property Alliance (IIPA) filed quarterly disclosures explicitly referencing "issues related to intellectual property and China" — lobbying on copyright protection, enforcement, and market access for U.S. creative industries. IIPA spent $10,000 per quarter across three consecutive quarters.

    PhRMA, the pharmaceutical industry's lobbying powerhouse, spent $50,000 per quarter on issues including "international intellectual property and market access policy issues," "China outbound investment policy issues," and "supply chain policy issues." PhRMA's PAC — the Better Government Committee — also made 663 contributions to members of Congress, making it the most prolific political donor among the organizations lobbying on these issues.

    The Telecommunications Industry Association (TIA) spent $80,000 per quarter lobbying on "China competitiveness," "ICT Cybersecurity," and "subsea cable security" — reflecting infrastructure vulnerability concerns tied to Chinese exploitation of U.S. technology networks.

    The semiconductor equipment sector formed a concentrated lobbying bloc. Lam Research, Applied Materials, and KLA Corp. each spent approximately $60,000–$80,000 per quarter lobbying on CFIUS policy, China export controls, and technology transfer restrictions. Applied Materials also operates a PAC that made 106 contributions to members of Congress, with bipartisan giving patterns.

    The Information Technology Industry Council (ITI), representing major tech companies, was the single highest spender among these organizations at approximately $720,000 per quarter, lobbying on cybersecurity, China trade policy, and technology competitiveness. ITI's PAC made 154 contributions to congressional campaigns.

    Even Nike Inc. was active, spending $250,000–$256,000 per quarter lobbying on trade secret protection, counterfeiting, and China trade issues. Nike's Federal PAC made 474 contributions, frequently at the $2,500–$5,000 level.

    In the biosecurity space, Twist Bioscience Corp. spent $75,000 per quarter on lobbying related to Chinese access to U.S. synthetic biology and genomics capabilities — a newer front in the broader China intellectual property theft battle.

    PAC Money Flows to Committee Members

    Several organizations lobbying on these issues directed PAC contributions to members of the Senate Judiciary Committee itself:

    • Sen. Thom Tillis (R-NC) received contributions from both the American Intellectual Property Law Association PAC and the Masimo Corporation PAC.
    • Sen. Mazie Hirono (D-HI) received contributions from both the AIPLA PAC and the Intellectual Property Owners Association PAC.
    • The Consumer Technology Association PAC was the most active overall, with 402 total contributions across multiple election cycles reaching dozens of members on both sides of the aisle.

    What Congress Could Act On

    While no specific legislation is formally linked to the hearing, at least five active bills in the 119th Congress align directly with its focus:

    S.330 — CCP IP Act: A Senate bill that targets Chinese Communist Party-linked intellectual property theft. As a Senate bill squarely within Judiciary Committee jurisdiction, it is a strong candidate for discussion.

    S.672 — Protect America's Innovation and Economic Security from CCP Act of 2025: A broader Senate measure aimed at protecting American innovation from CCP threats, potentially encompassing technology transfer restrictions, research security, and enhanced enforcement.

    H.R.1486 — Economic Espionage Prevention Act: The most legislatively advanced of the group — it has already passed the House and been referred to the Senate. The bill strengthens legal tools for combating economic espionage.

    H.R.1122 — China Technology Transfer Control Act of 2025: A House bill addressing restrictions on sensitive technology transfers to Chinese entities.

    H.R.4081 — Foreign Adversary Federal Offense Act of 2025: Would create new federal criminal offenses or enhance penalties for actions taken on behalf of foreign adversaries.

    The Economic Espionage Prevention Act's referral to the Senate makes it particularly ripe for the committee's attention at this US innovation theft hearing in 2026.

    What to Watch at the China Theft Innovation Hearing

    There is bipartisan interest on the issue. The 23-member committee includes senators who have been vocal on China policy from different angles. The Republican majority of 13 members includes hawkish voices on China like Sens. Josh Hawley (R-MO), Ted Cruz (R-TX), Marsha Blackburn (R-TN), and Eric Schmitt (R-MO). The Democratic side features Sen. Adam Schiff (D-CA), who brings intelligence committee experience, and Sen. Richard Blumenthal (D-CT), who has focused on consumer protection and technology issues.

    Access the Legis1 platform for comprehensive political news, data, and insights.